drugset / Trial / NCT07199335
Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs
Phase 4
Recruiting
100 enrolled
Massachusetts General Hospital
Fenway Community Health · collabViiV Healthcare · collab
NaSingle-groupOpen-labelPrevention
Summary
The goal of this study is to determine the feasibility and impact of delivering long-acting injectable cabotegravir HIV pre-exposure prophylaxis and suite of support services to adults who inject non-prescription drugs who are risk for HIV through known sexual risk.
Timeline
- Start
- 2026-02-24
- Primary completion
- 2028-12
- Completion
- 2028-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cabotegravir | Small molecule | — | — |